PRMT5 and head and neck squamous cell carcinoma: Others have reported that PRMT5 is overexpressed in HNSCC (71), and inhibition of PRMT5 by EPZ015666 (GSK3235025) reduces H3K4me3-mediated Twist1 transcription and suppresses the carcinogenesis and metastasis of HNSCC (72).